Suchergebnisse - "Habtemariam, Solomon"

PubPharm (308)

81

A review of medications used to control and improve the signs and symptoms of COVID-19 patients

enthalten in: European journal of pharmacology | 2020

von Hushmandi, K. | Bokaie, S. | Hashemi, M. | +6

82

A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19

enthalten in: Archives of medical research | 2020

von Sahebnasagh, A. | Mojtahedzadeh, M. | Najmeddin, F. | +6

83

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?

enthalten in: Archives of medical research | 2020

von Habtemariam, S. | Nabavi, S. | Banach, M. | +4

84

Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?

enthalten in: Biochimie | 2020

von Dowran, R. | Nabavi, S. | Habtemariam, S. | +6

85

Chemistry and Pharmacology of Alkylamides from Natural Origin

enthalten in: Revista Brasileira de farmacognosia | 2020

von Elufioye, T. | Habtemariam, S. | Adejare, A.

86

Chemistry and Pharmacology of Alkylamides from Natural Origin

enthalten in: Revista Brasileira de farmacognosia | 2020

von Elufioye, T. | Habtemariam, S. | Adejare, A.

87

Repurposing therapeutic agents and herbal medicines to defeat viral nemesis

enthalten in: Drug development research | 2020

von Caputo, L. | Lentini, G. | Habtemariam, S.

88

Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19 : Shoot the messenger!

enthalten in: Journal of cellular and molecular medicine | 2020

von Habtemariam, S. | Berindan-Neagoe, I. | Cismaru, C. | +5

89

May we target double-membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection?

enthalten in: Cell biology international | 2020

von Shahmohamadnejad, S. | Nabavi, S. | Habtemariam, S. | +4

90

Pharmacological treatments of COVID-19

enthalten in: Pharmacological reports | 2020

von Sahebnasagh, A. | Avan, R. | Saghafi, F. | +11